Literature DB >> 32910062

Modeling an integrated HIV prevention and care continuum to achieve the Ending the HIV Epidemic goals.

Samuel M Jenness1, Jordan A Johnson1, Karen W Hoover2, Dawn K Smith2, Kevin P Delaney2.   

Abstract

OBJECTIVE: We sought to evaluate, which combinations of HIV prevention and care activities would have the greatest impact towards reaching the US Ending the HIV Epidemic (EHE) plan goals of HIV incidence reduction.
DESIGN: A stochastic network-based HIV transmission model for men who have sex with men (MSM), calibrated to surveillance estimates in the Atlanta area, a focal EHE jurisdiction.
METHODS: Model scenarios varied HIV screening rates under different assumptions of how HIV-negative MSM would be linked to PrEP initiation, and rates of HIV care linkage and retention for those screening positive.
RESULTS: A ten-fold relative increase in HIV screening rates (to approximately biannual screening for black and Hispanic MSM and quarterly for white MSM) would lead to 43% of infections averted if integrated with PrEP initiation. Improvements focused only on black MSM would achieve nearly the same outcome (37% of infections averted). Improvements to HIV care retention would avert 41% of infections if retention rates were improved ten-fold. If both screening and retention were jointly improved ten-fold, up to 74% of cumulative infections would be averted. Under this scenario, it would take 4 years to meet the 75% EHE goal and 12 years to meet the 90% goal for Atlanta MSM.
CONCLUSION: Reaching the EHE 75% incidence reduction goals by their target dates will require immediate and substantial improvements in HIV screening, PrEP, and ART care retention. Meeting these EHE goals in target jurisdictions like Atlanta will be possible only by addressing the HIV service needs of black MSM.

Entities:  

Mesh:

Year:  2020        PMID: 32910062      PMCID: PMC7606461          DOI: 10.1097/QAD.0000000000002681

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  45 in total

1.  EpiModel: An R Package for Mathematical Modeling of Infectious Disease over Networks.

Authors:  Samuel M Jenness; Steven M Goodreau; Martina Morris
Journal:  J Stat Softw       Date:  2018-04-20       Impact factor: 6.440

2.  The effect of HAART on HIV RNA trajectory among treatment-naïve men and women: a segmental Bernoulli/lognormal random effects model with left censoring.

Authors:  Haitao Chu; Stephen J Gange; Xiuhong Li; Donald R Hoover; Chenglong Liu; Joan S Chmiel; Lisa P Jacobson
Journal:  Epidemiology       Date:  2010-07       Impact factor: 4.822

3.  A Separable Model for Dynamic Networks.

Authors:  Pavel N Krivitsky; Mark S Handcock
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2014-01-01       Impact factor: 4.488

4.  Addressing Gaps in HIV Preexposure Prophylaxis Care to Reduce Racial Disparities in HIV Incidence in the United States.

Authors:  Samuel M Jenness; Kevin M Maloney; Dawn K Smith; Karen W Hoover; Steven M Goodreau; Eli S Rosenberg; Kevin M Weiss; Albert Y Liu; Darcy W Rao; Patrick S Sullivan
Journal:  Am J Epidemiol       Date:  2019-04-01       Impact factor: 4.897

5.  Viral dynamics of acute HIV-1 infection.

Authors:  S J Little; A R McLean; C A Spina; D D Richman; D V Havlir
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

6.  Community viral load as a measure for assessment of HIV treatment as prevention.

Authors:  William C Miller; Kimberly A Powers; M Kumi Smith; Myron S Cohen
Journal:  Lancet Infect Dis       Date:  2013-03-25       Impact factor: 25.071

7.  Ending the HIV epidemic in the USA: an economic modelling study in six cities.

Authors:  Bohdan Nosyk; Xiao Zang; Emanuel Krebs; Benjamin Enns; Jeong E Min; Czarina N Behrends; Carlos Del Rio; Julia C Dombrowski; Daniel J Feaster; Matthew Golden; Brandon D L Marshall; Shruti H Mehta; Lisa R Metsch; Ankur Pandya; Bruce R Schackman; Steven Shoptaw; Steffanie A Strathdee
Journal:  Lancet HIV       Date:  2020-03-05       Impact factor: 12.767

8.  Towards an integrated primary and secondary HIV prevention continuum for the United States: a cyclical process model.

Authors:  Tim Horn; Jennifer Sherwood; Robert H Remien; Denis Nash; Judith D Auerbach
Journal:  J Int AIDS Soc       Date:  2016-11-17       Impact factor: 5.396

9.  What Will It Take to Reduce HIV Incidence in the United States: A Mathematical Modeling Analysis.

Authors:  Allison Perry; Parastu Kasaie; David W Dowdy; Maunank Shah
Journal:  Open Forum Infect Dis       Date:  2018-01-06       Impact factor: 3.835

10.  The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States.

Authors:  Ethan D Borre; Emily P Hyle; A David Paltiel; Anne M Neilan; Paul E Sax; Kenneth A Freedberg; Milton C Weinstein; Rochelle P Walensky
Journal:  J Infect Dis       Date:  2017-10-17       Impact factor: 7.759

View more
  9 in total

1.  Assessing the Role of Long-Acting Cabotegravir Preexposure Prophylaxis of Human Immunodeficiency Virus: Opportunities and Aspirations.

Authors:  Myron S Cohen; Raphael J Landovitz
Journal:  J Infect Dis       Date:  2021-01-04       Impact factor: 5.226

2.  What Will It Take to End HIV in the United States? : A Comprehensive, Local-Level Modeling Study.

Authors:  Anthony Todd Fojo; Melissa Schnure; Parastu Kasaie; David W Dowdy; Maunank Shah
Journal:  Ann Intern Med       Date:  2021-09-21       Impact factor: 25.391

3.  Characterization of Risk Factors Among Individuals with a History of Incarceration Presenting to a Sexually Transmitted Infections Clinic: Implications for HIV and STI Prevention and Care.

Authors:  Matthew J Murphy; Brooke G Rogers; Laura C Chambers; Alexandra Zanowick-Marr; Drew Galipeau; Madeline Noh; Ty Scott; Siena C Napoleon; Jennifer Rose; Philip A Chan
Journal:  AIDS Patient Care STDS       Date:  2022-08       Impact factor: 5.944

4.  Optimizing HIV Prevention Efforts to Achieve EHE Incidence Targets.

Authors:  Evin U Jacobson; Katherine A Hicks; Justin Carrico; David W Purcell; Timothy A Green; Jonathan H Mermin; Paul G Farnham
Journal:  J Acquir Immune Defic Syndr       Date:  2022-04-01       Impact factor: 3.771

5.  Modeling the Impact of HIV-1 Nucleic Acid Testing Among Symptomatic Adult Outpatients in Kenya.

Authors:  Deven T Hamilton; Clara Agutu; Joseph B Babigumira; Elise van der Elst; Amin Hassan; Evanson Gichuru; Peter Mugo; Carey Farquhar; Thumbi Ndung'u; Martin Sirengo; Wairimu Chege; Steven M Goodreau; Adam Elder; Eduard J Sanders; Susan M Graham
Journal:  J Acquir Immune Defic Syndr       Date:  2022-05-05       Impact factor: 3.771

6.  Adaptation and psychometric evaluation of a scale to measure oral pre-exposure prophylaxis-related stigma among key and vulnerable populations in Kenya.

Authors:  Kaitlyn Atkins; Lena Kan; Abednego Musau; Jason Reed; Daniel Were; Diwakar Mohan
Journal:  J Int AIDS Soc       Date:  2022-07       Impact factor: 6.707

7.  Agent-based model projections for reducing HIV infection among MSM: Prevention and care pathways to end the HIV epidemic in Chicago, Illinois.

Authors:  Wouter Vermeer; Can Gurkan; Arthur Hjorth; Nanette Benbow; Brian M Mustanski; David Kern; C Hendricks Brown; Uri Wilensky
Journal:  PLoS One       Date:  2022-10-17       Impact factor: 3.752

8.  HIV Testing Trends Among Persons with Commercial Insurance or Medicaid - United States, 2014-2019.

Authors:  Kirk D Henny; Weiming Zhu; Ya-Lin A Huang; Ashley Townes; Kevin P Delaney; Karen W Hoover
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-06-25       Impact factor: 17.586

9.  Population Impact and Efficiency of Improvements to HIV PrEP Under Conditions of High ART Coverage Among San Francisco Men Who Have Sex With Men.

Authors:  Adrien Le Guillou; Susan Buchbinder; Hyman Scott; Albert Liu; Diane Havlir; Susan Scheer; Samuel M Jenness
Journal:  J Acquir Immune Defic Syndr       Date:  2021-12-01       Impact factor: 3.771

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.